While CCL2 is expressed in carcinoma cells, studies have indicated that CCL2 expression in the stroma is a more significant prognostic indicator in breast cancer (Fujimoto et al., 2009; Yao et al., 2016b). Here, CCL2 is linked to breast carcinoma.